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Özet
Prostatın inflamatuar myofibroblastik tümörleri (İMT), sarkomlar ve iğsi hücre-
li karsinomları klinik ve histopatolojik olarak taklit edebilen nadir lezyonlardır. Bu-
rada sunulan olgu, normal prostat spesifik antijen düzeyleri ve kronik yakınmala-
rı olan, tıbbi tedaviye yanıtsız infravezikal tıkanma bulguları nedeni ile suprapubik 
prostatektomi uygulanan 63 yaşında bir hastadır. Eksizyon materyalinin histopa-
tolojik incelenmesi fokal nükleer pleomorfizm, hiperkromazi gösteren, mononükle-
er  iltihabi infiltrasyon ve miksoid değişiklikler içeren, düzgün sınırlı, iğsi hücreli bir 
lezyonu ortaya koydu. Mitoz nadirdi. İmmunhistokimyasal çalışmada düz kas aktini 
ve vimentin pozitif, anaplastik lenfoma kinaz -1 fokal pozitif, S-100 ve pansitoke-
ratin negatifti.  Lezyon inflamatuar myofibroblastik tumor olarak tanı aldı. İMT’nin 
prostatın malign iğsi hücreli lezyonlarından ayrımı gereksiz ileri tedavi işlemleri-
nin önüne geçilmesi için şarttır.
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Abstract
Inflammatory myofibroblastic tumors (IMT) of the prostate are very rare lesions 
that may mimic sarcomas and spindle carcinomas both clinically and histopatho-
logically. The case presented here is a 63-year-old patient, with normal prostate 
specific antigen levels and a chronic history of complaints, who underwent to 
suprapubic prostatectomy due to the infravesical obstruction symptoms that are 
resistant to medical therapy.   Histopathological examination of the excision ma-
terial revealed a well demarcated spindle cell lesion with focal nuclear polymor-
phism, hyperchromasia, mononuclear inflammatory infiltration and myxoid areas. 
Mitosis was rare. Immunohistochemically smooth muscle actin and vimentin were 
positive, anaplastic lymphoma kinase-1 was focal positive, S-100 and pancyto-
keratin were negative. The lesion was diagnosed as an inflammatory pseudotu-
mor. Differential diagnosis of the IMT from malignant spindle cell tumors of the 
prostate is crucial to prevent overtreatment.
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Introduction
Stromal lesions of the prostate are rare and consisted of a 
number of benign and malignant lesions that closely resemble 
each other [1,2]. The differential diagnosis, which is crucial for 
appropriate treatment, may be challenging. Inflammatory myo-
fibroblastic tumor of the prostate (IMT; synonym: pseudosarco-
matous spectrum fibromyxoid tumor of the prostate, inflamma-
tory pseudotumor of the prostate) is one of these rare lesions 
and stands in the benign side of the stromal lesions.
Case Report
A 63-year-old male patient has admitted to the department of 
urology with difficulty in starting urine flow and pollakiuria for 
2 years. Despite the 6 months of 5 alpha reductase (Finasterid 
5mg) and alpha blocker (Tamsulosin HCL 0.4mg) medication, 
the symptoms persisted.  Prostate specific antigen (PSA) was 
1.22 ng/ml, and prostate volume was measured as 186cc in 
ultrasound. In uretherocystoscopia prostatic urethra was longer 
than normal (7cm) and prostate median lobe and lateral lobes 
were narrowing the urethra. Qmax, volume and residue in uro-
flow, performed without Foley catheter, were 12ml/sec, 75cc 
and 197 cc respectively. Bladder capacity, compliance, and sen-
sitivity were normal in filling cystometry. There was no detru-
sor hyperactivity. Pressure flow study showed high pressure-low 
flow. Digital rectal examination finding was compatible with a 
1.5(+) adenoma.
The patient had no history of a previous operation or instru-
mentation. 
Since the patient was not an appropriate candidate for trans-
urethral resection, suprapubic prostatectomy was performed 
with a clinical presumptive diagnosis of benign prostatic hy-
perplasia.
Macroscopically the resection material was composed of two 
separate tissues (originally a single mass resected in two por-
tions by the surgeon because of its size)   with smooth surface, 
gray-white in color. One of the pieces was 9x4x4cm and the 
other was 7x5x4cm, total weight: 141gr. The cut surfaces were 
solid, gray-white in color and had a fibrillary appearance.  Ex-
tensive sampling was done.
Microscopically the well demarcated lesion that was composed 
of spindle cells forming long, transecting bundles, was pushing, 
but not infiltrating the normal prostate tissue. Focal nuclear hy-
perchromasia and pleomorphism were observed. Mitosis was 
rare. There was no necrosis or atypical mitotic figures. There 
were foci of mononuclear inflammatory response, including 
plasma cells, and myxoid degeneration (Figure 1). Vimentin, 
smooth muscle actin were positive, anaplastic lymphoma ki-
nase -1 (ALK-1) was focal positive, S-100 and pancytokeratin 
were negative in immunohistochemical study. ALK positivity 
was confirmed with fleurocein in-situ hybridization (FISH) with 
DAKO split signal FISH probe (Figure 2).
The case was diagnosed as inflammatory myofibroblastic tu-
mor. The patient is under follow up, for 5 years and no recur-
rence occurred.
Discussion
Inflammatory myofibroblastic tumors are rare lesions that can 
be seen in a variety of organs (e.g. lungs, heart, liver, vagina, 
kidneys) [2, 3]. The ethiopathogenesis is uncertain. The term 
“inflammatory pseudotumor” was first used by Umiker and Iven-
son in 1954 for desricribing 4 cases in lung [2].    Compared with 
the respiratory system the term “inflammatory pseudotumor” 
is relatively new in genitourinary tract.  First “reactive pseudo-
sarcomatous response” in genitourinary tract was described in 
bladder in 1980 [4], and the first IMT in prostate was described 
4 years later by Hafiz et al [5]. 
IMTs are spindle cell lesions that are believed to be originate 
from the myofibroblastic cells [6]. They may mimic malignant 
lesions both clinically and microscopically. In clinic, IMTs may 
show rapid grow and high PSA levels. Microscopically they may 
be confused with sarcomas and spindled carcinomas, which will 
lead to cystoprostatectomy and pelvic lymph node dissection. 
In our case the PSA levels were not suggestive of malignancy 
and the clinical symptoms of the patient were existing nearly 
for two years, without a rapid increase. The size of our lesion 
is larger than the previously reported IMTs of prostate [1, 7]. 
This slow pace of growth may explain the relatively larger size 
of the lesion. If the lesion showed rapid growth and caused 
more dramatic symptoms, the patient would have admitted to 
the hospital earlier and probably the lesion would be excised in 
an earlier phase.  In microscopic examination there was focal 
nuclear pleomorphism and hyperchromasia. Mitosis was rare 
Figure 1. Photomicrograph reveals transecting spindle cell bundles intermixed 
with mononuclear inflammatory infiltrate (HE x100)
Figure 2. Signal splitting in FISH. Note one green and one red signal splitted 
from each other by a distance more than two signal diameters (arrows) (ALK 
FISH  x1000)
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and necrosis was absent. In sarcomas and spindled carcinomas, 
nuclear pleomorphism and hyperchromasia are more prominent 
with a high mitotic rate and invasive pattern. Foci of necrosis 
may also be present.
Postoperative spindle cell nodule (PSCN), and IMT were thought 
to be different entities, but now they are believed to be reflect-
ing the same lesion with some minor differences, particularly 
in patient history. PSCN develops after an instrumentation or 
operation, and tends to be smaller than IMT [1, 6]. Our patient 
had no history of a previous operation or instrumentation. 
Embryonal, fibroblastic, and smooth muscle nodules are the 
stromal nodules of benign prostatic hyperplasia (BPH) [1]. They 
are all well demarcated nodules and may contain pleomorphic 
spindle cells and hyperchromatic pleomorphic nuclei [8], like 
IMT. All BPH nodules are positive for S-100 [1]. In our case 
S-100 was negative. Although one may speculate that it may 
be possible that some IMT nodules were being reported as BPH 
nodules in the past, and the real incidence of IMT may be higher 
than the current data, after nearly 30 years of its first descrip-
tion, there is still a small number of case of reports in the litera-
ture regarding prostatic IMTs. 
Immunohistochemical ALK-1 positivity may be seen in genito-
urinary tract, most commonly in bladder, IMTs. In a study by 
Montgomery et al, FISH ALK results and immunohistochemical 
ALK results were showed to be compatible [7]. The ALK positiv-
ity suggests that IMTs of genitourinary tract are true neoplastic 
processes rather than reactive ones. ALK positivity may not be 
a predictor of recurrence [7].
IMTs of prostate are rare lesions and their distinction from sar-
comas and spindle cell carcinomas is crucial to prevent an over-
treatment. Most IMTs of prostate are treated with transurethral 
resection, an interventional therapy that aims to resolve the 
symptoms rather than a total resection of the mass. Since IMTs 
are true neoplastic processes, close follow up of the patients 
with IMT diagnosis may be important. 
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